search
Back to results

Diffusion Tensor (DTI) for the Assessement of Therapeutic Evolution of Patients With Acute Lumbar Radiculalgia (DiTi-Aïe)

Primary Purpose

Lumbar Radiculopathy, Magnetic Resonance Imaging, Diffusion Tensor Imaging

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
DTI sequence acquisition
Sponsored by
Lille Catholic University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Lumbar Radiculopathy focused on measuring Lumbar Radiculopathy, Magnetic Resonance Imaging, Diffusion Tensor Imaging, Prognostic

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 ans
  • Patient with Lumbar Radiculalgia (L4, L5 or S1)
  • Pain VAS (Visual analog scale) > 30/100
  • Less than 3 months of evolution
  • With a radiculalgia superior or equal to lumbalgia
  • Disco radicular conflict, verified by MRI
  • Able to receive information
  • Affiliated to French social security

Exclusion Criteria:

  • History of chronic lumbalgia and radiculalgia
  • History of lumbar surgery
  • Recent episode (less than 6 months) with the same radicular topography
  • Bilateral radicular compression on MRI
  • Patient requiring emergency surgery
  • Evolutive disease interfering with pain assesment (neoplasia, inflammatory rheumatism, peripheral neuropathy, central neurological disease)
  • MRI contraindication

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Lumbar radiculopathy

    Arm Description

    Patients with acute lumbar radiculopathy (less than 3 months of evolution)

    Outcomes

    Primary Outcome Measures

    Predictive performance of DTI imaging on the therapeutic evolution
    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is the diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The objective is to know if the interpretation of DTI allow to predict the therapeutic evolution of patients. For instance, the patients will need in the future oral drugs? Or they will need rather an infiltration? Or they will need rather a surgery?

    Secondary Outcome Measures

    Correlation between DTI parameters and pain intensity
    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is the diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The intensity of pain will be self evaluated by the visual analogue scale (VAS). This scale is between 0 and 10 (in cms) being absence of pain and 10 intolerable pain.
    Correlation between DTI parameters evolution and neuropathic pain
    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is the diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The presence of neuropathic pain will be evaluated by the Neuropathic Pain Symptom Inventory (NPSI) scale. This is a self-questionnaire.The tool evaluates mean pain intensity in the last 24h in a verbal numeric scale from zero (no pain) to 10 (worst imaginable pain). Total pain intensity score may be calculated by the sum of 10 descriptors.
    Correlation between DTI parameters evolution and disability
    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is a diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The disability will be measured by the Oswestry Disability Index (ODI). The final score/index ranges from 0-100. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound.

    Full Information

    First Posted
    August 4, 2020
    Last Updated
    August 6, 2020
    Sponsor
    Lille Catholic University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04507113
    Brief Title
    Diffusion Tensor (DTI) for the Assessement of Therapeutic Evolution of Patients With Acute Lumbar Radiculalgia
    Acronym
    DiTi-Aïe
    Official Title
    Prognostic Value Assessment of Biomarkers in Acute Lumbar Radiculalgia : Contribution of the Diffusion Tensor in Magnetic Resonance Imaging
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2020
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    January 1, 2021 (Anticipated)
    Primary Completion Date
    July 1, 2021 (Anticipated)
    Study Completion Date
    July 1, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Lille Catholic University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Diffusion tensor imaging (DTI) is a non-invasive MRI technique offering a functional approach that provides morphological information about the microstructures of the nerve roots. DTI is a widely used neuroimaging technique and is a current topic of research in the field of peripheral nerve imaging.The aim of the study is to determine the prognostic quality of the DTI parameters to predict the therapeutic evolution of patients with lumbar radiculalgia at 6 months.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Lumbar Radiculopathy, Magnetic Resonance Imaging, Diffusion Tensor Imaging
    Keywords
    Lumbar Radiculopathy, Magnetic Resonance Imaging, Diffusion Tensor Imaging, Prognostic

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    150 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Lumbar radiculopathy
    Arm Type
    Experimental
    Arm Description
    Patients with acute lumbar radiculopathy (less than 3 months of evolution)
    Intervention Type
    Other
    Intervention Name(s)
    DTI sequence acquisition
    Intervention Description
    DTI sequence acquisition
    Primary Outcome Measure Information:
    Title
    Predictive performance of DTI imaging on the therapeutic evolution
    Description
    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is the diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The objective is to know if the interpretation of DTI allow to predict the therapeutic evolution of patients. For instance, the patients will need in the future oral drugs? Or they will need rather an infiltration? Or they will need rather a surgery?
    Time Frame
    6 months
    Secondary Outcome Measure Information:
    Title
    Correlation between DTI parameters and pain intensity
    Description
    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is the diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The intensity of pain will be self evaluated by the visual analogue scale (VAS). This scale is between 0 and 10 (in cms) being absence of pain and 10 intolerable pain.
    Time Frame
    6 months
    Title
    Correlation between DTI parameters evolution and neuropathic pain
    Description
    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is the diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The presence of neuropathic pain will be evaluated by the Neuropathic Pain Symptom Inventory (NPSI) scale. This is a self-questionnaire.The tool evaluates mean pain intensity in the last 24h in a verbal numeric scale from zero (no pain) to 10 (worst imaginable pain). Total pain intensity score may be calculated by the sum of 10 descriptors.
    Time Frame
    6 months
    Title
    Correlation between DTI parameters evolution and disability
    Description
    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is a diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The disability will be measured by the Oswestry Disability Index (ODI). The final score/index ranges from 0-100. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound.
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Age ≥ 18 ans Patient with Lumbar Radiculalgia (L4, L5 or S1) Pain VAS (Visual analog scale) > 30/100 Less than 3 months of evolution With a radiculalgia superior or equal to lumbalgia Disco radicular conflict, verified by MRI Able to receive information Affiliated to French social security Exclusion Criteria: History of chronic lumbalgia and radiculalgia History of lumbar surgery Recent episode (less than 6 months) with the same radicular topography Bilateral radicular compression on MRI Patient requiring emergency surgery Evolutive disease interfering with pain assesment (neoplasia, inflammatory rheumatism, peripheral neuropathy, central neurological disease) MRI contraindication
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Amélie LANSIAUX, MD, PhD
    Phone
    03.20.22.52.69
    Email
    lansiaux.amelie@ghicl.net
    First Name & Middle Initial & Last Name or Official Title & Degree
    Amel BOULAFA, Master
    Phone
    03.20.22.52.69
    Email
    boulafa.amel@ghicl.net
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jean-François BUDZIK, MD, PhD
    Organizational Affiliation
    Lille CU
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Diffusion Tensor (DTI) for the Assessement of Therapeutic Evolution of Patients With Acute Lumbar Radiculalgia

    We'll reach out to this number within 24 hrs